Algernon Pharmaceuticals Inc. filed its Annual on Nov 25, 2022 for the period ending Aug 31, 2022. In this report its auditor, Smythe Ratcliffe, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.16 CAD | 0.00% | +14.29% | +146.15% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+146.15% | 2.55M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- AGN Stock
- News Algernon Pharmaceuticals Inc.
- Algernon Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt